Monash University in Melbou rne, Australia, is paving the way in restoring human eyesight with this revolutionary device, which will enter human clinical trials in 2021. The cortical vision device, called Gennaris, is in part an electronic implant that sits on the surface of the brain and works in tandem with a camera headset to restore vision to blind patients. While wearing the headgear, the camera captures the scene and sends the images wirelessly to the implanted device. Gennaris converts that information into electrical pulses, delivered through hundreds of hair-thin microelectrodes, to stimulate the visual cortex of the brain, which over time learns to interpret those signals as images.